Lan Luo is a Neurology physician.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
710 W 168th St
Third Floor
New York, NY 100323726
Telephone
212-305-9718Registry record last updated 14 Jul 2015.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Tanabe Pharma America, Inc.Program year20251 payment
- Boston Scientific CorporationProgram year20258 payments
- Medtronic, Inc.Program year20257 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
90.6%Aromatic Amino Acid Decarboxylation Inhibitor40.3%Carbidopa-Levodopa71%Carbidopa-Levodopa Er19%Rytary8%Carbidopa2%Part D<11 patientsCholinesterase Inhibitor11.1%Rivastigmine69%Donepezil Hcl31%Part D<11 patients+ 12 more classes in this area
Cardiovascular
5.7%Beta blocker3.6%Propranolol Hcl Er56%Propranolol Hcl44%Part D<11 patientsalpha-Adrenergic Agonist2.1%Midodrine Hcl100%Part D≥12 patientsMusculoskeletal
1.9%gamma-Aminobutyric Acid-ergic Agonist1.9%Baclofen100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
Atte Meretoja
University of Helsinki
Bruce Miller, MD
University of California, San Francisco (UCSF)
Dennis Selkoe, MD
Brigham and Women's Hospital
Ettore Beghi
Mario Negri Institute for Pharmacological Research
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”